China Japan Usa India city Mumbai virus covid-19 patient Coronavirus China Japan Usa India city Mumbai

Mumbai company gets approval for clinical trial of drug on coronavirus patients

Reading now: 318
www.livemint.com

Mumbai-based Glenmark Pharmaceuticals today said has received approval from the Drug Controller General of India to conduct clinical trials of antiviral drug favipiravir on coronavirus patients.

The product is a generic version of Avigan of Fujifilm Toyama Chemical Co. Ltd., Japan. This news sent Glenmark shares as much as 9% higher today. "Favipiravir has demonstrated activity against influenza viruses and has been approved in Japan for the treatment of novel influenza virus infections.

Recently in the past few months, post the outbreak of COVID-19, multiple clinical trials have been initiated on COVID-19 patients in China, Japan and in the US," Glenmark said.

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA